Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03588936
What this trial is testing

Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

Who this might be right for
Acute LeukemiaChronic LeukemiaLymphoma+1 more
Medical College of Wisconsin 2
Early research (Phase 1)Ended earlyNCT00943293
What this trial is testing

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

Who this might be right for
PreleukemiaMyeloproliferative DisordersLymphoma+2 more
University of Chicago 1
Early research (Phase 1)Active Not RecruitingNCT04098393
What this trial is testing

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT00048412
What this trial is testing

Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H

Who this might be right for
Myelodysplastic DisordersLeukemiaMultiple Myeloma+2 more
Baylor College of Medicine 40
Not applicableStudy completedNCT03654404
What this trial is testing

A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 29
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Not applicableStudy completedNCT03349931
What this trial is testing

Prospective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis in Patients With Onco-haematological Diseases
Assistance Publique - Hôpitaux de Paris 350
Not applicableEnrolling By InvitationNCT06925685
What this trial is testing

Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product

Who this might be right for
Hematologic MalignanciesSolid Tumors
Allogene Therapeutics 50
Testing effectiveness (Phase 2)WithdrawnNCT03986086
What this trial is testing

MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancy
Nelson Chao
Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04395222
What this trial is testing

Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

Who this might be right for
Hematologic MalignancyBone Marrow Transplant
Weill Medical College of Cornell University 21
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Not applicableLooking for participantsNCT07763054
What this trial is testing

Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+6 more
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine 30
Large-scale testing (Phase 3)Study completedNCT00750737
What this trial is testing

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

Who this might be right for
Invasive Fungal InfectionsHematologic Malignancies
M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Looking for participantsNCT06926595
What this trial is testing

Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

Who this might be right for
Graft-versus-Host Disease (GVHD)Hematologic MalignanciesAllogeneic Stem Cell Transplantation
Milton S. Hershey Medical Center 41
Testing effectiveness (Phase 2)WithdrawnNCT04127721
What this trial is testing

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplant RecipientHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
Not applicableStudy completedNCT00513175
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more
University of California, San Francisco 44
Testing effectiveness (Phase 2)UnknownNCT04809181
What this trial is testing

Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
First Affiliated Hospital of Zhejiang University 95
Early research (Phase 1)Ended earlyNCT00800150
What this trial is testing

Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
City of Hope Medical Center 6
Next Page